Exact Sciences Corp.

NASDAQ:EXAS   3:59:56 PM EDT
55.84
-2.16 (-3.72%)
4:02:09 PM EDT: $55.33 -0.51 (-0.91%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)7.25B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$346.7 Million
Adjusted EPS-$0.62
See more estimates
10-Day MA$56.33
50-Day MA$76.28
200-Day MA$94.91
See more pivots

EXACT SCIENCES CORP Stock, NASDAQ:EXAS

441 CHARMANY DRIVE, MADISON, WI 53719
United States of America
Phone: 608-284-5700
Number of Employees: 1977
www.exactsciences.com

Description

Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company develops the Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has a collaboration, license, and purchase agreement with Genzyme Corporation; and license agreement with MAYO Foundation for Medical Education and Research. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.